Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Longitudinal Studies of the Identification, Prevalence and the Lifespan of Rapid-Onset Dystonia-Parkinsonism and Other Movement Disorders
This study is currently recruiting participants.
Verified by National Institute of Neurological Disorders and Stroke (NINDS), November 2008
Sponsors and Collaborators: Wake Forest University
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: National Institute of Neurological Disorders and Stroke (NINDS)
ClinicalTrials.gov Identifier: NCT00682513
  Purpose

The purposes of this study are to identify persons with rapid-onset dystonia-parkinsonism (RDP) or mutations of the RDP gene, document prevalence of the disease, and map its natural history.


Condition
Dystonia
Parkinsonism

Genetics Home Reference related topics: early-onset primary dystonia familial paroxysmal nonkinesigenic dyskinesia
MedlinePlus related topics: Dystonia Movement Disorders
U.S. FDA Resources
Study Type: Observational
Study Design: Family-Based, Prospective
Official Title: Longitudinal Studies of the Identification, Prevalence and the Lifespan of Rapid-Onset Dystonia-Parkinsonism and Other Movement Disorders

Further study details as provided by National Institute of Neurological Disorders and Stroke (NINDS):

Primary Outcome Measures:
  • RDP phenotype [ Time Frame: any length of time to onset of dystonic symptoms ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

whole blood, tissue (saliva samples)


Estimated Enrollment: 100
Study Start Date: April 2008
Estimated Study Completion Date: March 2012
Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
RDP
Persons and family members with a diagnosis of RDP, atypical parkinsonism, focal dystonia, and other movement disorders.

Detailed Description:

Rapid-onset dystonia-parkinsonism (RDP) is a rare, movement disorder with variable characteristics ranging from sudden onset (hours to days) of severe dystonic spasms to gradual onset of writer's cramp. RDP has elements of both dystonia and Parkinson's disease—two neurological diseases with motor and neuropsychological symptoms that hinder the quality of life. An internal trigger associated with extreme physiological stress has been reported prior to abrupt symptom onset of RDP.

This study, which is a continuation of an earlier study begun by Dr. Allison Brashear, aims to more clearly identify the characteristics associated with RDP and to explore whether mutations in the RDP gene are associated with atypical dystonias, Parkinson's disease, and other movement disorders.

Physicians from around the world who suspect their patients may have RDP or other movement disorders will send videotaped neurological assessments of their patients and blood samples for genetic analysis.

  Eligibility

Ages Eligible for Study:   6 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Selection will take place predominantly via primary care clinics, i.e., physician referrals when patients present with a movement disorder suspicious for RDP.

Criteria

Inclusion Criteria:

  • Clinical diagnosis of RDP.

Exclusion Criteria:

  • N/A
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00682513

Contacts
Contact: Deborah F. Hill, MA 336-716-5418 dfhill@wfubmc.edu
Contact: Allison Brashear, MD abrashea@wfubmc.edu

Locations
United States, North Carolina
Wake Forest University Health Sciences Recruiting
Winston-Salem, North Carolina, United States, 27157-1043
Contact: Deborah F. Hill, MA     336-716-5418     dfhill@wfubmc.edu    
Principal Investigator: Allison Brashear, MD            
Sponsors and Collaborators
Wake Forest University
Investigators
Principal Investigator: Allison Brashear, MD Professor and Chair, Department of Neurology, Wake Forest University Health Sciences
  More Information

Responsible Party: Wake Forest University Health Sciences ( Allison Brashear, Professor and Chair, Department of Neurology )
Study ID Numbers: R01NS058949, BG05-556, 1R01NS058949-01A1
Study First Received: May 20, 2008
Last Updated: November 20, 2008
ClinicalTrials.gov Identifier: NCT00682513  
Health Authority: United States: Federal Government;   United States: Institutional Review Board

Keywords provided by National Institute of Neurological Disorders and Stroke (NINDS):
dystonia
parkinsonism
rapid-onset dystonia-parkinsonism
RDP

Study placed in the following topic categories:
Dystonic Disorders
Signs and Symptoms
Ganglion Cysts
Dystonia 12
Movement Disorders
Basal Ganglia Diseases
Central Nervous System Diseases
Neurologic Manifestations
Dystonia
Parkinsonian Disorders
Brain Diseases
Dyskinesias

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009